Inflammation is associated to volume status in peritoneal dialysis patients

References

• Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405–416
   PubMed Web of Science ®Google Scholar
• Kaisar M, Isbel N, Johnson DW. Cardiovascular disease in patients with chronic kidney disease. A clinical review. Minerva Urol Nefrol. 2007;59:281–297
   PubMedGoogle Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
   PubMed Web of Science ®Google Scholar
• Ortega O, Gallar P, Muñoz M, et al. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients. Nephron Clin Pract. 2004;97:c125–c130
   Google Scholar
• Cordeiro AC, Carrero JJ, Abensur H, Lindholm B, Stenvinkel P. Systemic and local inflammation in peritoneal dialysis: Mechanisms, biomarkers and effects on outcome. Contrib Nephrol. 2009;163:132–139
   PubMed Web of Science ®Google Scholar
• Unal A, Sipahioglu M, Oguz F, et al. Pulmonary hypertension in peritoneal dialysis patients: Prevalence and risk factors. Perit Dial Int. 2009;29:191–198
   PubMed Web of Science ®Google Scholar
• Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989;7:95–108
   PubMed Web of Science ®Google Scholar
• Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic–angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37:7–11
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356
   PubMed Web of Science ®Google Scholar
• Mosteller RD. Simplified calculation of body surface area. N Engl J Med. 1987;317:1098
   PubMed Web of Science ®Google Scholar
• Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC. Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol. 2011;34:360–365
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 2000;18:1207–1213
   PubMedGoogle Scholar
• Chawla LS, Krishnan M. Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodial Int. 2009;13:222–234
   PubMed Web of Science ®Google Scholar
• Gangji AS, Brimble KS, Margetts PJ. Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif. 2009;28:354–358
   PubMed Web of Science ®Google Scholar
• Ritz E, Dikow R, Morath C, Schwenger V. Salt – A potential ‘uremic toxin'? Blood Purif. 2006;24:63–66
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang L, Ji WJ, et al. Variation in dietary salt intake induces coordinated dynamics of monocyte subsets and monocyte-platelet aggregates in humans: Implications in end organ inflammation. PLoS One. 2013;8:e60332
   PubMed Web of Science ®Google Scholar
• Rodrigues Telini LS, de Carvalho Beduschi G, Caramori JC, Castro JH, Martin LC, Barretti P. Effect of dietary sodium restriction on body water, blood pressure, and inflammation in hemodialysis patients: A prospective randomized controlled study. Int Urol Nephrol. 2014;46:91–97
   PubMed Web of Science ®Google Scholar
• Beduschi GC, Telini LS, Caramori JC, Martin LC, Barretti P. Effect of dialysate sodium reduction on body water volume, blood pressure, and inflammatory markers in hemodialysis patients – A prospective randomized controlled study. Ren Fail. 2013;35:742–747
   PubMed Web of Science ®Google Scholar
• Avila-Díaz M, Ventura MD, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int. 2006;26:574–580
   PubMed Web of Science ®Google Scholar
• Kim SB, Chang JW, Lee SK, Park JS. Acute systemic inflammation is associated with an increase in peritoneal solute transport rate in chronic peritoneal dialysis patients. Perit Dial Int. 2004;24:597–600
   PubMed Web of Science ®Google Scholar
• Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69:1726–1732
   PubMed Web of Science ®Google Scholar
• Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–2162
   PubMed Web of Science ®Google Scholar
• Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307–1320
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41:1212–1218
   PubMed Web of Science ®Google Scholar
• Palomo-Piñón S, Mora-Villalpando CJ, Del Carmen Prado-Uribe M, et al. Inflammation and myocardial damage markers influence loss of residual renal function in peritoneal dialysis patients. Arch Med Res. 2014;45:484–488
   PubMed Web of Science ®Google Scholar
• Cho Y, Hawley CM, Johnson DW. Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol. 2014;2014:909373
   PubMedGoogle Scholar
• Bemelmans MH1, Gouma DJ, Buurman WA. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine. 1994;6:608–615
   PubMed Web of Science ®Google Scholar
• Watanabe H, Miyamoto Y, Honda D, et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83:582–592
   PubMed Web of Science ®Google Scholar
• Adesso S, Popolo A, Bianco G, et al. The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS One. 2013;8:e76778
   PubMed Web of Science ®Google Scholar
• Rossi M, Campbell KL, Johnson DW, et al. Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3–4 chronic kidney disease. Arch Med Res. 2014;45:309–317
   PubMed Web of Science ®Google Scholar
• Abbas SR, Liu L, Sipahioglu MH, et al. Comparison of bioimpedance techniques to detect changes in fluid status in hemodialysis patients. Blood Purif. 2014;37:48–56
   PubMed Web of Science ®Google Scholar
• Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Body composition measurements using bioimpedance analysis in peritoneal dialysis patients are affected by the presence of dialysate. Nephrology (Carlton). 2014;19:727–731
   PubMed Web of Science ®Google Scholar
• Malavolti M, Mussi C, Poli M, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21–82 years. Ann Hum Biol. 2003;30:380–391
   PubMed Web of Science ®Google Scholar